Table 4 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Serum immunoglobulin free light chains and their association with clinical phenotypes, serology and activity in patients with IgG4-related disease | Scientific Reports
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine - ScienceDirect
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
PDF) Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
November 18, 2022 Sebia, Inc. Karen Anderson Director of Regulatory 1705 Corporate Drive, Suite 400 Norcross, Georgia 30093 Re:
Rapid detection of serum free light chains by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry - Zelal Zuhal Kaya, Muhittin Serdar, Fehime Aksungar, Meltem Kilercik, Mustafa Serteser, Ahmet Tarik Baykal, 2023
cerebrospinal fluid (csF) κ:λ free light chain (FLc) ratio predicts... | Download Scientific Diagram
Clinical Immunology Immunoglobulin free light chains as an inflammatory biomarker of heart failure with myocarditis
Multiple myeloma: Detection of free monoclonal light chains by modified immunofixation electrophoresis with antisera against free light chains - ScienceDirect
Table 2 from Prevalence and clinical significance of abnormal serum kappa/ lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Heavy+light chain monitoring correlates with clinical outcome in multiple myeloma patients | Leukemia
![PDF] Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders The Experience at a District General Hospital in the United Kingdom | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/6459e5bc7cce768dafb951809da956e1c549f372/3-Figure1-1.png "PDF] Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders The Experience at a District General Hospital in the United Kingdom | Semantic Scholar")
PDF] Utility of Serum Free Light Chain Analysis When Screening for Lymphoproliferative Disorders The Experience at a District General Hospital in the United Kingdom | Semantic Scholar
Kappa free light chains index in the differential diagnosis of Multiple Sclerosis from Neuromyelitis optica spectrum disorders and other immune-mediated central nervous system disorders - ScienceDirect
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Table 1 from Investigation into the interference of the monoclonal antibody daratumumab on the free light chain assay. | Semantic Scholar
Development of a highly-sensitive multi-plex assay using monoclonal antibodies for the simultaneous measurement of kappa and lambda immunoglobulin free light chains in serum and urine - ScienceDirect
Biomolecules | Free Full-Text | Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements
Comparison of 2 Serum-Free Light-Chain Assays in CKD Patients
Method comparison of four clinically available assays for serum free light chain analysis
